| abstract |
The present invention relates to a medicament using a chlorophyllin (Phlorotannin) extracted from seaweed as an active ingredient, more specifically, matrix metalloproteinases in which plotannin decomposes the main components of the extracellular matrix of the connective tissue and the basement membrane (Matrix metalloproteinase) activity has been shown to be effective in inhibiting the activity of matrix metalloproteinases associated with wounds, cancer metastasis, periodontal disease, rheumatoid arthritis, inflammation, parathyroidism, diabetes, corneal ulcers, osteoporosis, gastric ulcers, trauma, wrinkles, The present invention relates to a composition for inhibiting matrix metalloproteinase (MMP) activity containing flortannin as an active ingredient used to prevent and treat diseases such as acne, AIDS, burns, arteriosclerosis and fractures. |